Freeman Roy Lester [Rocket]

Date	Name	Type	Security	Shares	Price	Value	Reported
06/30/2023	Inhibikase Therapeutics, Inc.	Grant	Stock Option (right to buy)	6.7k	$3.61	$24.1k	06/30/2023
06/24/2022	Inhibikase Therapeutics, Inc.	Grant	Stock Option (right to buy)	40k	$0.81	$32.4k	06/24/2022
06/25/2021	Inhibikase Therapeutics, Inc.	Grant	Stock Option (right to buy)	22.7k	$2.92	$66.2k	06/25/2021
12/22/2020	Inhibikase Therapeutics, Inc.	Grant	Stock Option (right to buy)	6.8k	$10.00	$68.2k	12/22/2020